Berkshire Hathaway Inc. (BRK-B) vs Johnson & Johnson (JNJ)
See how Berkshire Hathaway Inc. and Johnson & Johnson differ across market data and performance, so you can decide which asset best fits your strategy.
$507.43
NYSE
$254.68
NYSE
Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.
View Full PageKey Metrics Comparison
Berkshire Hathaway Inc.BRK-B
Market Cap$1.086T
Price$507.43
24h Change+0.63%
24h Volume$967.3K
Employees387,800
Shares OutstandingN/A
Johnson & JohnsonJNJ
Market Cap$613.753B
Price$254.68
24h Change+0.69%
24h Volume$2.09M
Employees138,200
Shares Outstanding2,407,216,971
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
BRK-B
63.9%JNJ
36.1%Volume Share
Share of combined 24h volume
BRK-B
31.6%JNJ
68.4%24h Performance
Price change over last 24 hours
BRK-B
0.63%JNJ
0.69%Price Comparison
Berkshire Hathaway Inc.
Johnson & Johnson